Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on September 1, 2004, reporting an amendment to the employment agreement of its Chairman, Kenneth W. Freeman. This amendment specifically addresses actions taken in the second quarter of 2004 concerning the calculation of Mr. Freeman's non-qualified benefit under the executive retirement supplemental plan. The key financial impact disclosed is a $10.3 million charge recorded by the Company in the second quarter of 2004. This charge is attributed to the acceleration of certain pension benefits, which occurred in conjunction with a recently completed CEO succession process. Investors should note this charge impacts the company's reported earnings for that quarter.
Key Highlights
- 1Amendment to Chairman Kenneth W. Freeman's employment agreement entered into on August 26, 2004.
- 2Amendment addresses the calculation of Mr. Freeman's non-qualified retirement benefit.
- 3Company recorded a $10.3 million charge in the second quarter of 2004 related to this matter.
- 4The charge is for the acceleration of certain pension benefits.
- 5The pension benefit acceleration is linked to a recently completed CEO succession process.
- 6The filing also lists an Exhibit 99.1, a Letter Agreement between the Company and Kenneth W. Freeman.
Frequently Asked Questions
This 8-K filing reports an amendment to the employment agreement of Quest Diagnostics' Chairman, Kenneth W. Freeman, and discloses a related $10.3 million charge taken in the second quarter of 2004.
The $10.3 million charge was recorded by the Company due to the acceleration of certain pension benefits for Mr. Freeman, stemming from actions taken regarding his executive retirement supplemental plan.
The acceleration of Mr. Freeman's pension benefits and the resulting charge occurred in connection with the recently completed CEO succession process.
This filing primarily concerns executive compensation and retirement benefits related to a leadership transition. It does not directly indicate changes in operational strategies or new business initiatives.